-
1 Comment
Meilleure Health International Industry Group Limited is currently in a long term downtrend where the price is trading 10.5% below its 200 day moving average.
From a valuation standpoint, the stock is 235.0% more expensive than other stocks from the Industrials sector with a price to sales ratio of 7.5.
Meilleure Health International Industry Group Limited's total revenue rose by 4.5% to $132M since the same quarter in the previous year.
Its net income has increased by 166.7% to $41M since the same quarter in the previous year.
Finally, its free cash flow grew by 621.9% to $50M since the same quarter in the previous year.
Based on the above factors, Meilleure Health International Industry Group Limited gets an overall score of 3/5.
| CurrencyCode | HKD |
|---|---|
| Exchange | HK |
| Industry | Conglomerates |
| Sector | Industrials |
| ISIN | BMG5975D1048 |
| Dividend Yield | 5.6% |
|---|---|
| Market Cap | 1B |
| Target Price | 2.62 |
| PE Ratio | 28.0 |
| Beta | 0.67 |
Meilleure Health International Industry Group Limited, an investment holding company, engages in industrial hemp, healthcare-related, trading, agency service, property investment and leasing, and property development businesses in Hong Kong, the People's Republic of China, and internationally. The company is involved in the trading of construction materials; development and sale of residential properties; property investment and leasing activities; and sale of healthcare-related products. It also provides real estate agency services; cannabidiol downstream product application services; health management services, including anti-aging, aesthetic medicine, and other health consulting; and healthcare related product sales agency services. The company was formerly known as U-Home Group Holdings Limited and changed its name to Meilleure Health International Industry Group Limited in March 2017. Meilleure Health International Industry Group Limited is headquartered in Admiralty, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2327.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
